News & Events about Inmune Bio Inc.
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, April 24, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the Company), a clinical-stage immunology company focused ondeveloping treatments that harness a patients innate immune system to fight ...
Globe Newswire
2 months ago
BOCA RATON, Fla., April 03, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc.(NASDAQ: INMB)(the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that the Company has submitted an Investigational ...
Ticker Report
2 months ago
INmune Bio, Inc. (NASDAQ:INMB Get Rating) CFO David J. Moss acquired 2,500 shares of the businesss stock in a transaction dated Friday, March 17th. The shares were bought at an average price of $6.42 per share, with a total value of $16,050.00. Following the transaction, the chief ...
Globe Newswire
3 months ago
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Feb. 21, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the Company), a clinical-stage immunology company focused ondeveloping treatments that harness a patients innate immune system to fight ...
Globe Newswire
4 months ago
BOCA RATON, Fla., Feb. 08, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announces that it has received a combined approximately $6.4 ...